Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$250.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Omega Diagnostics Group Plc Issues FY 2013 Guidance Below Analysts' Estimates


Wednesday, 10 Apr 2013 02:00am EDT 

Omega Diagnostics Group Plc announced that for fiscal 2013, it expects revenue to be GBP11.26 million, slightly ahead of last year's result (March 31, 2013: GBP11.12 million), profit before tax (before acquisition costs, share based payments, IFRS-related discount unwinds and amortisation of intangible assets) to be approximately GBP0.8 million and will be stated after the restructuring costs of approximately GBP0.1 million reported at the interim results. According to I/B/E/S Estimates, analysts are expecting the Company to report pre-tax profit of GBP0.99 million on revenue of GBP11.60 million for fiscal 2013. 

Company Quote

17.5
0.25 +1.45%
23 Jul 2014